Hope William

Hope William is a Professor and Dame Sally Davies Chair of AMR Research at the University of Liverpool, serving as NIHR National Specialty Co-Lead for Infectious Diseases. His expertise lies in antimicrobial pharmacokinetics/pharmacodynamics, antifungal drug development, and combating antimicrobial resistance. He advises regulatory bodies like the FDA and EMA, authored international guidelines, and co-chaired major AMR conferences. He has supervised 16 clinical/PhD students and received notable awards including OBE (2021) and NIH Excellence Award (2006).

Research focuses on optimizing antimicrobial therapies, developing new antifungal agents (e.g., F901318), and addressing resistance mechanisms in cryptococcal meningitis. His work includes global initiatives like GARDP trials for neonatal sepsis treatments and leading national AMR platforms.

• Awards: OBE, Fellowships from American Academy of Microbiology and ESCMID
• Advisory Roles: FDA/EU Medicines Agency adviser, Global AMR Partnership committee member
• Grants: Wellcome Trust and MRC-funded training networks

Labs/Teams: Leads Liverpool AMR research initiatives and collaborates internationally on clinical mycology and drug development projects.